AI assistant
Sending…
CONMED Corp — Director's Dealing 2022
Jun 15, 2022
31971_dirs_2022-06-14_e97e4016-910e-424f-8958-ce70fc392878.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2022-06-13
Reporting Person: Garner Todd W (Executive Vice President & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-06-13 | Common Stock | S | 2662 | $99.79 | Disposed | 0 | Direct |
Footnotes
F1: The sale reported was effected pursuant to a previously adopted Rule 10b5-1 Trading Plan.
More from CONMED Corp
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 18